Capricor Therapeutics Inc (FRA:4LN2)
€ 3.7 +0.37 (+10.98%) Market Cap: 206.04 Mil Enterprise Value: -22.90 Mil PE Ratio: 0 PB Ratio: 0.85 GF Score: 54/100

Q4 2021 Capricor Therapeutics Inc Earnings & Recent Corporate Update Call Transcript

Mar 10, 2022 / 09:30PM GMT
Release Date Price: €4.04 (+1.00%)
Operator

Good day and welcome to the Capricor Therapeutics Incorporated fourth-quarter and full year 2021 earnings call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. AJ Bergmann, Chief Financial Officer. Please go ahead, sir.

AJ Bergmann
Capricor Therapeutics, Inc. - CFO

Thank you. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates; our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies; our plans to present or report additional data; our plans regarding regulatory filings; potential regulatory developments involving our product candidates; potential milestone payments; and our possible uses of existing cash and investment resources.

These forward-looking statements are based on the current information, assumptions, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot